Physician

Chakra Pani Chaulagain, MD

According to 2025 Medicare claims, Chakra Chaulagain, MD (NPI: 1487824124) practices hematology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is CLEVELAND CLINIC FLORIDA A NONPROFIT CORPORATION (NPI: 1215989298; TIN: 340714585) and primary practice location at 33331-3609. Chaulagain is affiliated with the Cleveland Clinic Florida Integrated Health (ACO ID: A3588), participating under the MSSP model.

Chaulagain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 235 traditional Medicare patients, billed 975 HCPCS/CPT codes, and received $69,681 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,217 prescription claims across 185 beneficiaries totaling $10,158,392 in drug costs, led by Revlimid (Lenalidomide). 2016 DME data shows 24 claims. Open Payments data shows 136 records totaling $516,422. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $691,136 to $69,681. In contrast, Part D prescription costs have moved sharply higher in recent years, from $481,017 to $10,158,392. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2015 Medicare payment: $691,136 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $982,823 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,188,138 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,149,232 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,244,734 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,827,522 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,935,767 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,247,259 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,376,400 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $69,681 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201533030,294$691,136
201639364,549$982,823
201732493,188$1,188,138
201834887,332$1,149,232
201941793,521$1,244,734
202038684,852$1,827,522
202132595,109$1,935,767
202230773,630$2,247,259
202329845,818$1,376,400
2024235975$69,681

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.1M$10M2015 Drug cost: $481,017 (USD; Tot_Drug_Cst)2016 Drug cost: $1,085,595 (USD; Tot_Drug_Cst)2017 Drug cost: $897,814 (USD; Tot_Drug_Cst)2018 Drug cost: $2,059,602 (USD; Tot_Drug_Cst)2019 Drug cost: $4,318,814 (USD; Tot_Drug_Cst)2020 Drug cost: $5,511,528 (USD; Tot_Drug_Cst)2021 Drug cost: $6,912,629 (USD; Tot_Drug_Cst)2022 Drug cost: $8,323,382 (USD; Tot_Drug_Cst)2023 Drug cost: $8,304,980 (USD; Tot_Drug_Cst)2024 Drug cost: $10,158,392 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201564424$481,017
2016101685$1,085,595
2017102703$897,814
2018106734$2,059,602
20191321,072$4,318,814
20201321,093$5,511,528
20211521,154$6,912,629
20221521,106$8,323,382
20231721,074$8,304,980
20241851,217$10,158,392

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.5K$3.0K2016 Medicare payment: $2,955 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R24$2,955
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more2121$144
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more118314$111
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes2159$98
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more116153$71
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's124165$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide2145,978$4,060,238
LenalidomideLenalidomide711,988$1,005,532
PomalystPomalidomide371,036$878,154
JakafiRuxolitinib Phosphate491,470$754,554
CerdelgaEliglustat Tartrate22616$701,850

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.92$24,412Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.44$492,010Alexion Pharmaceuticals, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Chakra Pani Chaulagain, MD?

Tedicare shows public-source Medicare data for Chakra Pani Chaulagain, MD (NPI 1487824124), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chakra Pani Chaulagain, MD have ACO affiliation data?

Chakra Pani Chaulagain, MD is shown with ACO affiliation data for Cleveland Clinic Florida Integrated Health (MSSP, ACO ID A3588).

What billing organization is linked to Chakra Pani Chaulagain, MD?

Chakra Pani Chaulagain, MD is linked to CLEVELAND CLINIC FLORIDA A NONPROFIT CORPORATION (billing NPI 1215989298) in the available physician profile data.

Does Chakra Pani Chaulagain, MD have Open Payments data?

Chakra Pani Chaulagain, MD has 136 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.